Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GeoPharma to launch desloratadine tablets

This article was originally published in The Tan Sheet

Executive Summary

GeoPharma can commercially launch a generic version of Schering Corp.'s Clarinex desloratadine tablets (5 mg) beginning July 2012, under a settlement agreement with Schering, Sepracor and the University of Massachusetts. "The new product launch may be a prescription or over-the-counter product depending on its status at the time of launch," Largo, Fla.-based GeoPharma notes in a Jan. 20 announcement. The company will have six months of marketing co-exclusivity to sell the allergy relief product. The settlement resolves all Hatch-Waxman litigation related to the desloratadine tablets triggered when GeoPharma filed paragraph IV certification for the product
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS102534

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel